240 related articles for article (PubMed ID: 6719608)
41. [Myasthenia gravis: critical evaluation of the treatment].
De Assis JL
Arq Neuropsiquiatr; 1990 Mar; 48(1):55-70. PubMed ID: 2198862
[TBL] [Abstract][Full Text] [Related]
42. [Treatment of myasthenia].
Fève JR
Rev Prat; 1988 Oct; 38(22):1541-5. PubMed ID: 3206137
[No Abstract] [Full Text] [Related]
43. [Diagnosis and treatment of myasthenia gravis].
Ponseti J; Espín E; Armengol M
Med Clin (Barc); 2000 Sep; 115(7):264-70. PubMed ID: 11013152
[No Abstract] [Full Text] [Related]
44. Mycophenolate mofetil and myasthenia gravis.
Ciafaloni E
Lupus; 2005; 14 Suppl 1():s46-9. PubMed ID: 15803932
[TBL] [Abstract][Full Text] [Related]
45. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
Saulat B; Maertens P; Hamilton WJ; Bassam BA
Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
[No Abstract] [Full Text] [Related]
46. Biology of myasthenia gravis.
Lindstrom J; Dau P
Annu Rev Pharmacol Toxicol; 1980; 20():337-62. PubMed ID: 6992700
[No Abstract] [Full Text] [Related]
47. Plasmapheresis: a new treatment modality for the patient with severe myasthenia gravis.
Eppel M; Streib EW
Nebr Med J; 1982 Apr; 67(4):72-4. PubMed ID: 7088214
[No Abstract] [Full Text] [Related]
48. [Treatment of juvenile myasthenia gravis].
Arroyo HA
Medicina (B Aires); 2019; 79 Suppl 3():71-76. PubMed ID: 31603848
[TBL] [Abstract][Full Text] [Related]
49. [Treatment of myasthenia].
Anosov NN; Dogel' LV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(11):1649-54. PubMed ID: 5369966
[No Abstract] [Full Text] [Related]
50. [Immunological and therapeutic aspects of myasthenia gravis (author's transl)].
Ghezzi M; Taiuti R; Marconi G
Riv Patol Nerv Ment; 1981; 102(1):12-28. PubMed ID: 6285444
[TBL] [Abstract][Full Text] [Related]
51. Surgical outcome in thymic tumors with myasthenia gravis after plasmapheresis--a comparative study.
Sarkar BK; Sengupta P; Sarkar UN
Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1007-10. PubMed ID: 18682429
[TBL] [Abstract][Full Text] [Related]
52. Myasthenia gravis.
Barboi AC; Meriggioli MN
Clin Neuropharmacol; 2000; 23(6):291-5. PubMed ID: 11575862
[No Abstract] [Full Text] [Related]
53. Therapeutic strategies for myasthenia gravis.
Keys PA; Blume RP
DICP; 1991 Oct; 25(10):1101-8. PubMed ID: 1803801
[TBL] [Abstract][Full Text] [Related]
54. Myasthenia gravis: life transforming treatments.
Goodger E
Nurs Mirror; 1981 Sep; 153(11):40-4. PubMed ID: 6912548
[No Abstract] [Full Text] [Related]
55. Treatment strategies in myasthenia gravis.
Genkins G; Sivak M; Tartter PI
Ann N Y Acad Sci; 1993 Jun; 681():603-8. PubMed ID: 8357209
[No Abstract] [Full Text] [Related]
56. Thymectomy: a recommended procedure for myasthenia gravis.
Morris J
J Neurosurg Nurs; 1981 Oct; 13(5):226-33. PubMed ID: 6315901
[No Abstract] [Full Text] [Related]
57. Clinical experience in more than 2000 patients with myasthenia gravis.
Genkins G; Kornfeld P; Papatestas AE; Bender AN; Matta RJ
Ann N Y Acad Sci; 1987; 505():500-13. PubMed ID: 2446559
[TBL] [Abstract][Full Text] [Related]
58. Effect of plasmapheresis in myasthenia gravis.
Perlo VP; Shahani BT; Huggins CE; Hunt J; Kosinski K; Potts F
Ann N Y Acad Sci; 1981; 377():709-24. PubMed ID: 6951495
[No Abstract] [Full Text] [Related]
59. Management of myasthenia gravis.
Lancet; 1972 Apr; 1(7754):780-1. PubMed ID: 4111252
[No Abstract] [Full Text] [Related]
60. [Thymectomy in the management of myasthenia].
Balzereit F; Bay V; Otto H; Rittmeyer P; Sobirey C
Z Neurol; 1972; 201(2):136-59. PubMed ID: 4112645
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
